0001213900-22-018928.txt : 20220408
0001213900-22-018928.hdr.sgml : 20220408
20220408160131
ACCESSION NUMBER: 0001213900-22-018928
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220407
FILED AS OF DATE: 20220408
DATE AS OF CHANGE: 20220408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahal Jeetinder Singh
CENTRAL INDEX KEY: 0001882877
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39138
FILM NUMBER: 22816937
MAIL ADDRESS:
STREET 1: C/O JASPER THERAPEUTICS, INC.
STREET 2: 2200 BRIDGE PARKWAY, SUITE 102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Jasper Therapeutics, Inc.
CENTRAL INDEX KEY: 0001788028
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 842984849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 6505491400
MAIL ADDRESS:
STREET 1: 2200 BRIDGE PKWY SUITE #102
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Amplitude Healthcare Acquisition Corp
DATE OF NAME CHANGE: 20190912
4
1
ownership.xml
X0306
4
2022-04-07
0
0001788028
Jasper Therapeutics, Inc.
JSPR
0001882877
Mahal Jeetinder Singh
C/O JASPER THERAPEUTICS, INC.
2200 BRIDGE PKWY, SUITE #102
REDWOOD CITY
CA
94065
0
1
0
0
See Remarks
Stock Option (right to buy)
3.12
2022-04-07
4
A
0
48441
0.00
A
2032-04-07
Voting Common Stock
48441
48441
D
1/4th of the shares subject to the option shall vest on March 21, 2023, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Chief Operating Officer, Chief Financial Officer and Corporate Secretary
/s/ Jeet Mahal
2022-04-08